3-乙酰基苯甲酰胺 | 78950-32-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3-乙酰基苯甲酰胺
• 英文名称: 3-acetylbenzamide
• CAS: 78950-32-0
• 化学式: C₉H₉NO₂
• 分子量: 163.176
• InChiKey: VTBUZDRQHQPEQY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  60.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-乙酰基苯甲酰胺 在 溴 、 溶剂黄146 作用下， 以83%的产率得到3-(2-溴乙酰基)苯甲酰胺
  参考文献：
  名称：

  WO2008/46598

  摘要：

  公开号：
• 作为产物：
  描述：

  3-(2-溴乙酰基)苯甲腈 在 sodium hydroxide 、 双氧水 、 potassium acetate 、 sodium iodide 作用下， 以 乙醇 、 水 为溶剂， 反应 7.0h， 生成 3-乙酰基苯甲酰胺
  参考文献：
  名称：

  Synthesis of 3-Substituted Benzamides and 5-Substituted Isoquinolin-1(2H)-ones and Preliminary Evaluation as Inhibitors of Poly(ADP-ribose)polymerase (PARP)

  摘要：

  Inhibitors of poly(ADP-ribose)polymerase (PARP) inhibit repair of damaged DNA and thus potentiate radiotherapy and chemotherapy of cancer. 3-Substituted benzamides and 5-substituted isoquinolin-1-ones have been synthesised and evaluated for inhibition of PARP. Reduction of 3-(bromoacetyl)benzamide, followed by treatment with base, gave RS-3-oxiranylbenzamide. Reduction of 3-(hydroxyacetyl)benzonitrile with bakers' yeast gave 'the R-diol which was converted to R-3-(1,2-dihydroxyethyl)benzamide. Similar reduction of 3-(acetoxyacetyl)benzonitrile led towards the S-diol which was converted to its cyclic acetonide. E-2-(2,6-Dicyanophenyl)-N,N-dimethylethenamine was formed by condensation of 2,6-dicyanotoluene with dimethylformamide dimethyl acetal (DMFDMA); cyclisation under acidic conditions afforded 5-cyanoisoquinolin-1-one. Heck coupling of 5-iodoisoquinolin-1-one with propenoic acid formed E-3-(1-oxoisoquinolin-5-yl)propenoic acid. 3-Oxiranylbenzamide, 5-bromoisoquinolin-1-one and 5-iodoisoquinolin-1-one were among the most potent inhibitors of PARP activity in a preliminary screen in vitro. (C) 1998 Elsevier Science Ltd, All rights reserved.

  DOI：

  10.1016/s0968-0896(98)00029-7

文献信息

• Selective NaOH-catalysed hydration of aromatic nitriles to amides
  作者：Thibault E. Schmid、Alberto Gómez-Herrera、Olivier Songis、Deborah Sneddon、Antoine Révolte、Fady Nahra、Catherine S. J. Cazin

  DOI：10.1039/c5cy00313j

  日期：——

  The selective synthesis of aromatic and heteroaromatic amides through base-catalysed hydration of nitriles was achieved using inexpensive and commercially available NaOH as the only catalyst. A wide range of nitriles was selectively converted to their corresponding amides. Kinetic studies show that the double hydration of nitriles towards undesirable carboxylic acids is negligible under our reaction

  使用廉价和可商购的NaOH作为唯一催化剂，可以通过碱催化腈的水合反应选择性合成芳族和杂芳族酰胺。各种各样的腈被选择性地转化为其相应的酰胺。动力学研究表明，在我们的反应条件下，腈类向不想要的羧酸的双重水合作用可以忽略不计。
• Therapeutic Compounds
  申请人：Zhou Xianbo

  公开号：US20070203154A1

  公开（公告）日：2007-08-30

  The invention provides a compound of formula I: wherein R 1 -R 6 , X, Y, and B have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of MAO-B enzyme function and are useful for improving cognitive function and for treating psychiatric disorders in animals.

  这项发明提供了一个式I的化合物： 其中R1-R6，X，Y和B具有本文所述的任何值，以及这些化合物的盐、包含这些化合物的组合物，以及包括给予这些化合物的治疗方法。这些化合物是MAO-B酶功能的抑制剂，对于改善认知功能和治疗动物的精神障碍是有用的。
• Gold Activation of Nitriles: Catalytic Hydration to Amides
  作者：Rubén S. Ramón、Nicolas Marion、Steven P. Nolan

  DOI：10.1002/chem.200901231

  日期：2009.9.7

  Innocence lost: The unprecedented gold‐mediated activation of nitriles is reported. A [(NHC)AuI]‐based catalytic system was found to be efficient for the nitrile hydration reaction of a broad spectrum of substrates that includes aromatic, heteroaromatic, and aliphatic examples.

  失去了纯真：据报道，前所未有的金介导的腈活化作用。发现基于[（NHC）Au I ]的催化体系对于包括芳香族，杂芳香族和脂肪族在内的多种底物的腈水合反应是有效的。
• PDE4B inhibitors
  申请人：Ibrahim N. Prabha

  公开号：US20060100218A1

  公开（公告）日：2006-05-11

  Compounds are described that are active on PDE4. Also described are crystal structures of PDE4B determined using X-ray crystallography, the use of PDE4B crystals and strucural information for identifying molecular scaffolds, for developing ligands that bind to and modulate PDE4B, and for identifying improved ligands based on known ligands.

  描述了对PDE4活性的化合物。还描述了使用X射线晶体学确定的PDE4B的晶体结构，利用PDE4B晶体和结构信息来识别分子支架，开发结合和调节PDE4B的配体，并根据已知配体来识别改进的配体。
• Anti-Cytokine Heterocyclic Compounds
  申请人：Goldberg Daniel

  公开号：US20060276496A1

  公开（公告）日：2006-12-07

  Heterocyclic compounds and analogues thereof and their use as inhibitors of Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2), and also to a method for preventing or treating a disease or disorder that can be treated or prevented by modulating the activity of MAPKAP-K2 in a subject and to pharmaceutical compositions and kits that include these MAPKAP-K2 inhibitors.

  杂环化合物及其类似物以及它们作为丝裂原活化蛋白激酶-2（MAPKAP-k2）抑制剂的用途，以及用于预防或治疗可以通过调节受试者中MAPKAP-K2活性来治疗或预防的疾病或紊乱的方法，以及包括这些MAPKAP-K2抑制剂的药物组合物和试剂盒。